INTRODUCTION
Minimal inhibitory concentration (MIC) data on veterinary mycoplasma species have been generated by numerous researchers who have employed tests using various liquid or solid media [1, 4-6, 10, 12, 13, 15-17, 19-22, 25-30, 32, 37-39, 42-44, 47, 48, 50, 51] . There has been little standardisation of procedures, making it difficult to compare MIC results from laboratory to laboratory [47] .
Although guidelines for in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents have recently been approved for veterinary bacteria [46] , these do not include mycoplasmas (mollicutes) which are both slow growing, highly fastidious and do not produce the turbidity in broth nor sufficient growth on agar necessary for conventional antibacterial testing.
At the 1996 biennial meeting of the International Organisation for Mycoplasmology (IOM) International Research Programme on Comparative Mycoplasmology (IRPCM), the Board recommended that standard protocols be drawn up for veterinary MIC assays.
In mycoplasmology the MIC is defined as the lowest concentration of antimicrobial that will inhibit visible growth or metabolism of a mycoplasma species after its optimal incubation period in vitro. Despite reservations about their clinical relevance, MICs are still generally considered to be the reference point for comparison and evaluation of other sensitivity tests and indeed the efficacy of all antimicrobials is described in terms of MICs. The minimum mycoplasmacidal concentration (MMC) is defined as the lowest concentration of antimicrobial that prevents growth after subculture onto or into antibiotic-free media (in practice, approximately a 99.99% kill).
The wide variation in nutritional requirements and cultural conditions of veterinary mycoplasmas and the preference of certain species for agar rather than broth medium, has tended to hamper the development of a universal veterinary mycoplasmal MIC assay. This has been compounded by the need and preference for different formulations of mycoplasma media by workers in the poultry, swine, cattle, other farm industries and those dealing with companion (pet) animals. These and other problems in relation to the susceptibility testing of mollicutes in general have been highlighted recently in "Molecular and Diagnostic Procedures in Mycoplasmology Vol. II" [3, 23] .
Recently attempts have been made to standardise and compare some veterinary MIC assay methods [4, 10, 42, 47] . The aim of this report is to discuss the factors which may influence veterinary MIC testing and to recommend basic procedures for carrying out such tests in the hope that consistent results can be achieved between laboratories in the future.
GENERAL TECHNICAL CONSIDERATIONS

Media
A standard medium for all veterinary mycoplasma MIC tests cannot currently be recommended because of the diversity of nutritional requirements of different mycoplasma species. In general, mycoplasma broth or agar giving the optimal growth of specific mycoplasmas or ureaplasmas should be employed in MIC tests. Suboptimal media giving poor growth may result in falsely low MIC values.
If penicillin or other β-lactam antibiotics (e.g. ampicillin), which are inactive against mycoplasmas because of their cell-wall deficiency, are incorporated to inhibit bacterial contamination, it should be borne in mind that they may interact with the compound under evaluation and that antagonism or even synergism might occur. It is therefore wise to establish if these phenomena occur with new antimicrobial agents and β-lactams before carrying out MICs using these bacterial inhibitors. However, penicillin G (1 000 IU⋅mL -1 ), ampicillin (1 000 µg⋅mL -1 ) or amoxycillin (1 000 µg⋅mL -1 ) with thallium acetate (500 µg⋅mL -1 ), included in the culture medium have been found not to influence the MICs of erythromycin, spiramycin, streptomycin, tetracycline, tiamulin or tylosin against certain avian mycoplasmas [47] . Thallium acetate is inhibitory to ureaplasmas and should be excluded from tests involving these microorganisms.
Many different formulations of mycoplasma and ureaplasma media have been described for the culture of veterinary mycoplasmas. Some of these media, cited in "Methods in Mycoplasmology Vol. 1" [9, 36] are listed in Tables I and II. Other media have been used by various workers [1, 4, 6, 7, 12, 17, 20, 21, 26, 37, 47, 49, 51] .
Most veterinary mycoplasmas can be grown in liquid or on solid media and can therefore be used in MIC tests employing either type of medium. An exception to this is the turkey pathogen, M. meleagridis, particularly fresh field isolates, which may be reluctant to grow or cause colour changes in liquid medium. MIC tests involving this mycoplasma species should therefore be carried out on solid media, at least until a suitable liquid medium has been developed.
Examples of media which have been used successfully by some investigators to carry out MIC assays against mycoplasmas from various animal host species, are shown in Table III .
Mycoplasmas develop only faint or no turbidity in broth cultures; consequently alternative methods are used to measure mycoplasmal growth. These include incorporation of substrates such as glucose, arginine or urea which are either fermented or hydrolysed by the mycoplasmas causing the medium to become acid or alkaline. These pH changes are usually detected by incorporating the pH indicator phenol red, into the mycoplasma broth, a colour change denoting mycoplasmal growth. Some mycoplasmas (e.g. M. iowae) metabolize both glucose and arginine and either substrate can be used to detect growth, [41] Solid Media Differential agar medium A8
Successfully used for the cultivation (Shepard and Combs) [36] of ureaplasmas from primates. Standard agar medium A5K
Successfully used for the isolation (Shepard and Lunceford) [36] and cultivation of ureaplasmas from animals.
Standard agar medium
Recommended for the isolation and (Taylor-Robinson et al.) [41] culture of animal ureaplasmas. Standard agar medium Developed for the isolation and (Howard et al.) [18] culture of bovine ureaplasmas.
For details refer to Methods in Mycoplasmology,Vol. 1 [36] . 
Identification of mycoplasmas/ureaplasmas
Ideally the species identification of mycoplasmas and ureaplasmas should be established before, or concurrently with, the testing of strains for susceptibility to antimicrobial agents. This involves the isolation and purification of strains to ensure that pure cultures are used in MIC tests. The large number of mycoplasma species inhabiting the respiratory and urogenital tracts of farm and domesticated animals and birds, many with similar colonial morphology, may make cloning obligatory. If this were not done, MIC test results would be on mixed cultures which would be misleading. If cloning is necessary then it is advisable to select several different clones and to carry out MIC tests on a mixture of these, to avoid selecting a minority resistant or sensitive sub-population. Cultures obtained from infection sites which are normally sterile, i.e. the joints, may be pure and in such instances broth cultures or agar blocks containing several colonies (≥ 5 colonies) can be used to prepare inocula for MIC tests. The purity of such cultures should also be checked in parallel.
Standardisation of inocula for MIC tests
It is important that mycoplasma inocula for MIC tests are carefully standardized. It has been recommended also that mycoplasmas in the logarithmic phase of growth be used for initial surveys with new antibiotics [23] .
An ATP-dependent luminometry method has also been reported recently for determining MICs of species that are highly fastidious or have long generation times and for agents with a short half life [3, 34] . Early logarithmic phase cultures are recommended for this method.
Antimicrobial agents
Ideally, antimicrobials should be obtained in powder form from the manufacturer accompanied by a statement of potency in relation to base ("as is" or anhydrous, in µg per mg) or as tablets, with details of optimum storage conditions, expiry date and solubility. Some compounds are available 
Storage
Most antimicrobial powders can be stored at +4°C in the dark (quinolones, rifampicin and chloramphenicol are light sensitive), over a drying agent such as silica gel. However, some compounds are best stored at a temperature of -20°C or below (e.g. netilmicin). Before use they should be allowed to come to room temperature before they are opened (to avoid condensation of water). Aliquots of stock solutions, at concentrations in excess of 1 000 mg⋅L -1 , can often be stored at -60°C for several months [8] , but it must be remembered that a stock solution frozen and then thawed should be used immediately and then discarded (repeated freezing and thawing of solutions is not acceptable because of loss of potency). Table VI gives a summary of information on storage, solubility and stability for many commonly used compounds.
It is preferable to use fresh stock antibiotic solutions, however some antimicrobial solutions can be stored at +4°C, frozen at -20°C or -70°C, for limited periods until required for use, without loss of potency. The tetracyclines do not fall into this category as they tend to precipitate on thawing and should always be tested fresh. It is important to check the stability of specific compounds at -20°C before testing. The half-lives of antimicrobial compounds under test conditions may be important when testing slow-growing mycoplasmas and can be obtained from the manufacturer or a recent chemical index. For use in MIC tests, fresh or freshly thawed, antimicrobial solutions are diluted in mycoplasma broth or agar to give the final required concentrations in MIC tests.
Preparation of antimicrobial solutions for MIC testing
Compounds can be tested directly as the formulation obtained (e.g. enrofloxacin hydrochloride), or in terms of the active base (e.g. enrofloxacin). Since different salts may differ considerably in their molecular weights, their active base contents will vary, weight for weight, and slightly different MIC values are likely to be obtained for different formulations. To avoid this, and to obtain consistent results between laboratories, antimicrobials should be tested in terms of their active base component. This is achieved by taking both the manufacturers stated purity and the salt content of the compound into account. The compound is then diluted allowing only for the base content. This is accomplished by applying a correction factor, calculated from the given purity of the compound, its molecular weight and the molecular weight of the active base. For example, if the stated purity of enrofloxacin hydrochloride is 80% and the molecular weights for enrofloxacin HCl and enrofloxacin base are 395.9 and 359.4 respectively, the correction factor is calculated as follows:
359.4 (MW enrofloxacin base) × 80 (purity) = 0.726.
(MW enrofloxacin HCl) 100
This figure is then applied to the amount of enrofloxacin HCl weighed to obtain the weight of enrofloxacin base present, e.g. Many commercial preparations of antimicrobials are water-soluble, but others, particularly those in the research stage, may require organic solvents, acids or alkalis to effect complete solubilization [31] . In general the compounds can be dissolved in a small volume (about one tenth the final volume) of the solvent and then made up to volume with deionized water. Agitation by vortexing, ultrasonic disintegration using a microprobe to disperse large particles, or mild warming may be required to obtain complete solutions.
Organic solvents which have been used include ethyl alcohol (EtOH), methyl alcohol (MeOH), dimethyl formamide (DMF) and dimethyl sulphoxide (DMSO), and can be used for many classes of antimicrobial agent. Acids such as 0.1 N hydrochloric acid or acetic acid can also be used for certain agents. 0.1 N sodium hydroxide is recommended for initially dissolving many of the water-insoluble quinolone antimicrobials. Salts of these latter agents are generally water-soluble. Following complete solubilization under acidic or alkaline conditions, it is often necessary to adjust the pH of the compound solutions to approximately pH 7.0 to avoid non-specific colour changes occurring in the higher drug concentrations in MIC tests.
To ensure that solvents are not inhibitory to the mycoplasmas it is important to include controls in MIC tests consisting of the solvent alone in mycoplasma broth at the same concentration as that used in the antimicrobial dilutions tested.
Where possible, antimicrobials should be tested at the correct pH for optimal in vitro activity, although this is governed by the ability of the mycoplasmas to grow well at that particular pH. MIC determinations based on colour changes in the medium due to pH shifts should not be affected if the correct end-point controls are included in the assay. It is debatable whether the in vitro pH is pertinent to the in vivo situation since the pH at different infection sites and within cells, varies considerably. Macrolides such as erythromycin and its newer analogues are more potent under alkaline conditions [2, 11] . A lesser, though significant, effect of pH on the testing of tetracyclines has also been reported [24] . Robertson et al. found that serum had no apparent binding effect on tetracycline, erythromycin or rosaramicin, but the expected decrease in macrolide activity against the human species Ureaplasma urealyticum at pH 6.0 was clearly evident [35] . This acidity, however, does reflect the level in the genital tract where antimicrobial activity is expressed. It may be necessary to adjust media to neutral pH, when dealing with mycoplasma or ureaplasma species isolated from other sites, although this may result in poorer growth of the microorganism.
Antimicrobial dilution ranges
Antibiotic dilution ranges are usually obtained by carrying out doubling dilutions, the highest final drug concentration frequently being 64 µg⋅mL -1 . In liquid MIC tests in microdilution plates, the drug concentrations are usually prepared at double the final concentration (e.g. 128 µg⋅mL -1 ) to allow for dilution with an equal volume of drug-free medium containing the mycoplasma inoculum. For MIC tests on solid medium the drug is incorporated into the agar plates at the final concentrations required, allowance being made for the larger volume of medium, e.g. if the final volume of medium per plate is 20 mL then 1 mL of drug solution at 20 times its final required concentration is incorporated in 19 mL of molten mycoplasma agar (50 ± 1°C) immediately before pouring the plates. In practice, 1 mL of the antimicrobial solution is pipetted into a sterile plastic universal container; the molten agar is then added, mixed by gentle inversion, and the plate poured immediately, to reduce the chance of possible heat inactivation of the compound under test. All plates should be of a uniform thickness. Drug dilutions can either be prepared in tubes or bottles using pipettes or automatic pipetters with sterile filter tips and then transferred to microdilution plate wells or molten agar, or they can be prepared directly in microtitre trays using various types of manual or automated microdilutors.
To minimize the chances of excessive drug "carry over" and other possible dilution errors, compounds may be diluted in tubes using a combination of doubling dilutions and dilutions in 10-fold series. This procedure involves carrying out a series of 10-fold dilutions of the compound concerned in sterile tubes or bottles; two doubling dilutions from each drug concentration produced by the 10-fold dilution procedure are then carried out. If the highest final required concentration is 100 µg⋅mL -1 , then the range of dilutions covered is similar to those produced by the conventional doubling dilution method starting at 64 µg⋅mL -1 .
Validation of equipment
All equipment including chemical balances, automatic pipetters, multi-channel micro-pipetters and inoculators should be routinely checked for accuracy of weighing or delivery. Incubators should be checked regularly for accuracy of temperature. 
Incubation conditions
Since most mycoplasmas and ureaplasmas grow well between 35°C and 37°C, a temperature of 36 ± 1°C is recommended for liquid and solid MIC assays, unless it is established that optimal growth occurs at a temperature outside this range.
In liquid microtitre MIC assays, it is essential that each well is securely sealed to prevent exchange of gases between wells which may result in false colour changes and erroneous MIC end-points. The seal on unused wells should be punctured to avoid lifting of the sealant by air expansion within the wells during incubation. If plates are incubated in a humidified cabinet at an appropriate incubation temperature and in a suitable gaseous environment, then all wells should be vented to allow escape of gaseous products of metabolism of the substrates in inoculated wells.
In solid medium assays, plates should be incubated in an atmosphere (e.g. aerobic, 95% N 2 + 5% CO 2 , or anaerobic) suitable for growing the mycoplasma species and strains under examination. Plates should be suitably dried prior to inoculation to allow absorption of the mycoplasma inoculum and to prevent cross-contamination of the mycoplasma species or strains. This is particularly important when automated multipoint inoculator heads delivering many different mycoplasma species or strains are used. It is important that the plates do not dry excessively during incubation as this can inhibit mycoplasmal growth and lead to erroneous MIC values. Drying can be avoided by including paper towelling moistened with sterile water containing an antifungal agent, such as sodium propionate, in the container containing the MIC plates.
Incubation times of different mycoplasma species and strains vary considerably. In liquid MIC tests incubation times are controlled by the time it takes for particular mycoplasmas or ureaplasmas to cause colour changes equivalent to pre-set pH controls. However, in agar MIC tests the incubation times should be sufficient to allow adequate growth of the slowest growing mycoplasma species under test.
MYCOPLASMA MIC METHODS
Both liquid and solid MIC methods have been used in determining MICs against veterinary mycoplasma species. Examples of these methods are the liquid method described by Tanner and Wu [39] , originally designed to test strains of M. gallisepticum and the solid agar method described by Hannan et al. [15] . Both of these methods are also applicable to testing mycoplasmas of human origin and have been used to test a variety of different mycoplasma species from various animal hosts. The results obtained by the two methods are in many instances, in close agreement (Tab. VII). This is in accordance with results obtained for the human species Ureaplasma urealyticum by Waites et al. [45] , where MIC 50 s and MIC 90 s obtained in broth were only four-fold lower than those on agar. It is therefore recommended that the Tanner and Wu method be adopted for mycoplasma species which grow well in broth and Hannan et al.'s modified method for those which grow either in broth or on agar. The liquid method is simple to carry out and is convenient for testing small numbers, while the agar system is ideal for evaluating large numbers of mycoplasma strains or species on the same agar plate, if a multipoint inoculation system (Denley Ltd, Billingshurst, Sussex, UK) is employed. The latter system would be the method of choice for testing strains of M. meleagridis. The liquid method could also be applied to tubes if small numbers of strains were to be tested. Further information on the MIC testing of mollicutes has been published recently by Bébéar and Robertson [3] .
Liquid MIC method
Preparation of stock mycoplasma cultures
Following primary isolation and identification, the mycoplasmas are grown at 36 ± 1°C in 10 mL broth medium containing the appropriate substrate (glucose, arginine, pyruvate or urea) and pH indicator (phenol red) until a colour change occurs (pink to orange-yellow for glucose and pyruvate fermenters, and orange-yellow to pink or red for arginine and urea catabolizers). Sterile glycerol (cryoprotectant) is then added (optional) to each culture to a final concentration of approximately 5% v/v and the cultures are divided into 5 × 1 mL aliquots in sterile containers and stored at -70°C.
Preparation of mycoplasma inocula for MIC testing
1. Thaw a 1-mL vial of frozen inoculum (-70°C) and add 4 mL of the appropriate medium set at pH 7.6 for glucose or pyruvate metabolizers, pH 6.8 for arginine or pH 6.0 to 6.5 for urea catabolizers. 2. Incubate the diluted culture at 36 ± 1°C until a definite acid or alkaline reaction is observed. 3. Record the time taken (in hours) for this reaction to occur. 4. Carry out a viable count immediately.
(To compare MICs obtained with lag phase cultures and those of logarithmic phase cultures, the thawed cultures can be used either directly or after incubation for 2 h at 36°C prior to inoculating the antibiotic dilutions. In the first instance steps 1 to 3 above for logarithmic phase cultures are omitted. One millilitre of the thawed culture is diluted in 9 mL of broth, and then vortexed for 5 s prior to carrying out a viable count. In the second instance, steps 1 to 3 for logarithmic cultures are also omitted. One millilitre of the thawed culture is diluted in 9 mL of growth medium, which after vortexing for 5 s is incubated for 2 h at 36°C. Thereafter viable counting procedures and MIC testing with the various inocula are identical). 
Viable counting method
Preparation of inocula for liquid MIC assays
1. Repeat the incubation procedure described in 3.1.2 ("Preparation of mycoplasma inocula for MIC testing") duplicating exactly the period of incubation.
2. Dilute the culture in mycoplasma broth to give between 10 3 ccu and 10 5 ccu per mL.
Modified MIC assay method of Tanner and Wu method [39]
1. Transfer 0.1 mL of each compound dilution to separate consecutive wells running horizontally on a microdilution plate (e.g. wells 1 through to 9).
2. To well number 10 add 0.2 mL of sterile mycoplasma broth at the appropriate pH (e.g. pH 7.6, for fermentative species, pH 6.8 for arginine catabolizers or pH 6.0-6.5 for ureaplasmas), as a sterility control.
3. To well number 11, add 0.2 mL of sterile mycoplasma broth adjusted to the required end-point (pH 6.8 for fermentative species, pH 7.6 for arginine catabolizers or pH 7.0-7.5 for ureaplasmasend point control).
4. To row number 12 add 0.1 mL of sterile mycoplasma broth at the appropriate pH.
5. In a separate row add 0.1 mL of antibiotic-free mycoplasma broth at the appropriate pH containing the antibiotic solvent at the same concentration used to dissolve the antimicrobial agent (solvent control).
6. Add 0.1 mL of mycoplasma inoculum to each well containing the antibiotic dilutions (wells 1 to 9), to the growth control well (well 12) and to the solvent control well.
Each MIC test should include a standard reference mycoplasma (e.g. the type strain of each species under investigation) with known susceptibilities against a range of antimicrobials, to confirm the validity of results and a standard antimicrobial agent e.g. (tiamulin) with known potencies against different species of veterinary mycoplasma.
The viable count of each mycoplasma challenge inoculum must be tested simultaneously with the MIC test to confirm the inoculum challenge as being between 10 3 and 10 5 ccu per mL.
7. Seal the microdilution plate with adhesive film as described above under "Viable counting method for liquid MIC assays" and incubate at 36 ± 1°C until the colour in the growth control well first matches that of the end-point control. To achieve this, plates must be examined at frequent intervals e.g. early morning, noon, late afternoon.
8. Record the initial MICs; the lowest antibiotic concentration to show no change in colour when the colour of the growth control well matches that of the pH end-point control. By definition this is the MIC value, however if plates are reincubated the end-point in liquid assay frequently shifts. For this reason a second reading is often taken and is referred to as the final MIC. Final readings can be recorded 7 days later or 14 days later for slow growing mycoplasma species such as M. hyopneumoniae, to determine the permanency of the initial MIC and is the lowest drug concentration in which no colour change occurs.
9. Continue incubating the plates until colour changes are complete in the wells containing the inoculum challenge control viable count.
Where MIC end-points are not achieved, or if the mycoplasma challenge falls outside the range 10 3 ccu⋅mL -1 to 10 5 ccu⋅mL -1 , tests must be repeated.
When the initial MIC and final MIC are the same or very similar, this may be indicative of a compound possessing mycoplasmacidal activity. However, this should be confirmed with MMC tests designed to demonstrate this property, such as diluting the contents of wells showing no colour change into antibiotic free mycoplasmal broth, followed by incubation, to check the absence of viable mycoplasmas. The dilution needs to be sufficient to prevent carry over of the inhibitory effect of each dilution of antibiotic and should be in the order of 1:25 to 1:50. Alternatively, mycoplasmal killing curve experiments may be carried out.
Solid agar MIC method
Viable counting method for solid MIC assays
1. Repeat the incubation procedure described in Section 3.1.2 ("Preparation of mycoplasma inocula for MIC testing") duplicating exactly the period of incubation.
2. Repeat steps 1 and 2 in Section 3.1.3 for liquid assay viable counts.
3. Transfer 2 µL of each mycoplasma dilution (in triplicate or more for greater accuracy) to the surface of freshly prepared and dried mycoplasma agar plates using a micropipetter and filter tip.
4. When the droplets of each suspension have been absorbed into the agar, incubate the plate at 36 ± 1°C under the appropriate atmospheric conditions (e.g. aerobic, 95% N 2 + 5% CO 2 or anaerobic) in sealed containers containing moistened paper towelling.
5. Incubate the seeded plates until the mycoplasma colonies are well developed on the plates inoculated with the lower dilutions of the mycoplasma suspension.
6. Select plates with a moderate growth of well separated colonies for counting. Avoid plates with low numbers of colonies.
7. Using a plate microscope or inverted microscope, count the number of colonies produced by each 2 µL droplet. The number of cfu per 2 µL of inoculum is the mean count from the three droplets (or more if additional droplets are counted).
Example:
If the colony counts from an individual 2 µL droplet for a 10 -5 dilution of inoculum are 30 cfu, 40 cfu and 35 cfu then the mean count would be 35 cfu per 2 µL. Therefore, to prepare inocula containing between 10 3 and 10 5 cfu per 2 µL for MIC testing, the concentrated culture should be diluted 10 -3 to give 3.5 × 10 3 cfu per 2 µL, which is within the recommended number for MIC testing.
Method (modified method of Hannan et al. [15])
1. Prepare agar plates containing a range of antimicrobial concentrations in 9 cm plastic petri dishes as described in Section 2.4.3. Also, prepare control drugfree plates. 2. Dry the plates. 3. Inoculate each plate with 2 µL containing 10 3 -10 5 cfu, of the mycoplasma culture to be tested using either micro-pipetters with filter tips, if only a small number of strains are to be tested, or a multi-point inoculator if larger numbers of strains are to be tested simultaneously. Whichever method is used, growth control plates (up to four to allow for possible bacterial or fungal contamination) without antibiotics must be included in each test.
Include the following controls:
(a) Reference strain (the type strain of each mycoplasma species being tested).
(b) Plates incorporating a reference antimicrobial (e.g. tiamulin).
(c) Plates incorporating the solvents used for each antimicrobial at the same concentration as that used in the highest concentration of the drugcontaining plates.
(d) A challenge inoculum growth control.
5. When the inoculum droplets have been absorbed, incubate the plates at 36 ± 1°C either aerobically or in an atmosphere of 95% N 2 + 5% CO 2 or anaerobically, if growth of the species is dependant on these latter conditions). Incubation should be maintained in moist conditions, in sealed plastic bags or gas jars, for a period sufficient to allow the slowest growing mycoplasma species to form clearly visible colonies, e.g. 7 days or longer if species such as M. hyopneumoniae or M. meleagridis are being investigated.
6. Record MICs by comparing the amount of mycoplasmal growth on each plate with that on the antibiotic-free growth control plate using a plate microscope or inverted microscope. The end-point (MIC) is the lowest concentration of antimicrobial to cause ≥ 50% inhibition of growth (e.g. reduction in density of growth and size of the colonies) compared with that on the control plate. A 50% end-point is taken to eliminate plates in which antibiotics show a "tailing effect" (very small numbers of mycoplasmas persisting beyond, what appears to be, the end-point).
Very often readings can be carried out macroscopically, but end-points should always be checked microscopically.
EXPRESSION OF RESULTS
Whether using liquid or solid MIC assays, MICs are expressed either in µg⋅mL -1 or mg⋅L -1 . When only small numbers of strains (n ≤ 10) are tested at the same time, it is usual to quote only the range of MICs recorded (e.g. MIC range = 0.1 µg⋅mL -1 to 10 µg⋅mL -1 ) to give an overall impression of the variance between strains. However, in larger studies, it is important to highlight the percentages of strains susceptible to particular concentrations of antimicrobials. This is accomplished by quoting the concentrations of compounds to which 50% or 90% of the strains are susceptible (MIC 50 or MIC 90 ). In comparing in vitro efficacies of marketed or research compounds the geometric mean MIC has been used by some workers. Examples of these calculations are shown in Table VIII .
INTERPRETATION OF RESULTS
The designations "sensitive", "resistant" or "intermediate" (moderately sensitive) are common to almost all methods of clinical laboratory testing, and are distinguished by the use of in vitro breakpoint antibiotic concentrations. Sensitive implies that the infection is likely to respond. Intermediate implies that an intermediate or indeterminate response is likely, except perhaps in special, defined circumstances, such as when high doses can be used, or the antibiotic is concentrated at the site of infection. Breakpoints are determined by attempting to take important pharmacological and microbiological factors into account, including serum binding, and are used routinely in bacterial infections. These factors have not yet been determined for most veterinary mycoplasmas in the various host species in which they may cause disease, although some investigators have attempted to establish breakpoints for some compounds against certain mycoplasmal pathogens [16, 22, 42, 43] (Tab. IX). This is due to the limited pharmacological data currently available on many antimicrobials in different animal species.
Until such information becomes available, a standardized assessment of sensitive, intermediate and resistant strains is difficult. It is therefore likely that in determining the antimicrobial susceptibilities of veterinary mycoplasmas, some variance in these designations will occur between laboratories.
TESTING FOR MYCOPLASMACIDAL ACTIVITY
Various tests have been used to determine the mycoplasmacidal activity of antimicrobials. These include:
1. Mycoplasmacidal activity determined by antibiotic dilution.
2. Mycoplasmacidal activity determined by filtration. 3. Mycoplasmacidal activity determined by subculture onto agar. 4. Mycoplasma killing curves.
Methods 1 and 2 have been designed specifically to remove the antibiotic from the surviving mycoplasmas in MIC tests and thus give a true indication of the mycoplasmacidal activity of antimicrobial agents. These methods have been described fully by Taylor-Robinson [40] .
Method 3 consists of subculturing all of the wells in liquid MIC tests using a 96-pin replicater/inoculator (Intek Services Ltd, Horley, Surrey, UK) onto mycoplasmal agar at the same time as recording the initial MICs and then incubating the plates to determine the lowest concentration of compound to inhibit mycoplasmal growth, the MMC. The results of this type of test are frequently very similar to the final MICs in MIC tests. However, the test does not remove the antibiotics from the mycoplasmas and relies on the very small amount of culture transferred on to replicater pins (2 µL) being diluted by diffusion into the agar gel. It is therefore possible that, in theory, a mycoplasmastatic effect might still be in operation in high concentrations of antibiotic. This method has been described by Hannan [14] .
Method 4, mycoplasmacidal killing curves, have been reviewed recently by Roberts [33] and are a measure of the mycoplasmacidal activity of the antibiotic being tested, thus providing a dynamic picture of antimicrobial action and interaction over time, based on serial colony counts. However, the repetitive colony counts that are required are tedious to perform and limit the number of antimicrobial concentrations that can be tested with any isolate. This type of test has been used to determine the mycoplasmacidal activities of certain quinolones and various other antibiotics against M. hyopneumoniae by Hannan et al. [15] . In view of the wide variation in nutritional requirements, cultural conditions and growth characteristics of veterinary mycoplasmas, it is not surprising that difficulties have been encountered in obtaining consistent MIC results from different laboratories. There are many factors which can influence the results of MIC tests involving veterinary mycoplasma species, including the composition and pH of the culture medium, the incubation conditions and the preference of certain mycoplasma species for agar rather than broth media. Whether using a liquid or solid MIC assay system, it is essential that, to avoid obtaining falsely low MIC results, optimal media for growing specific mycoplasma species are used, that cultures are pure and that mycoplasma inocula are carefully standardised. The recommended viable counts for inocula are 10 3 to 10 5 ccu⋅mL -1 for liquid assays and 10 3 to 10 5 cfu per plate for the agar dilution method. The growth phase of the organisms seems to be less important as lag phase cultures of M. gallisepticum, M. synoviae, M. bovis and M. hyopneumoniae have been shown to give very similar results to cultures in the logarithmic growth phase in liquid assays.
Antimicrobials should be stored according to the manufacturers recommendations and MICs determined in terms of their active base component, particularly when comparing results between laboratories. In liquid and solid MIC assays it is important that tests are carefully controlled, with growth, sterility, pH end-point (in liquid assays) and compound solvent controls and that standard reference mycoplasmas with established antibiotic sensitivity patterns are included in each experiment. In liquid MIC assays the microdilution plates must be adequately sealed to prevent exchange of gases between wells which might result in false colour changes and erroneous MIC endpoints and that the reading of liquid or solid MIC tests are carefully standardised. These factors, coupled with a dearth of standardisation of MIC procedures between laboratories to date, have made it almost inevitable that significant differences in results would occur. This report should aid in rectifying this problem. Inter-laboratory studies employing standardised methods with a common range of antimicrobial agents against standard veterinary mycoplasma species and strains are now needed to determine whether consistent results can be achieved.
